Interview with Dr. Ahmed Sheriff on CRP apheresis for COVID-19 patients

ntv has broadcast an interview with Dr. Ahmed Sheriff about CRP apheresis for COVID-19 patients. Among other things, they talk about the lack of funding for medical devices in the Corona Pandemic.

ZDF reports on CRP apheresis as salvation for COVID-19 patients


ZDF has reported on CRP apheresis treatment for COVID-19 patients.

At the Klinikum Havelhöhe, the therapy is now used for many severely ill Corona patients - with promising results. Nevertheless, all funding applications for a large clinical trial were unsuccessfully rejected. The trial is needed to make the therapy available to COVID-19 patients throughout Germany.

Forum Sanitas reports about the dark side of CRP


In the 2nd issue 2021 of Forum Sanitas an article about the dark side of CRP has been published.

The latest findings on the pathological action of CRP are summarized and the potential clinical applications of CRP apheresis in acute myocardial infarction, COVID-19, and other conditions are described.

ntv Wissen reports on CRP apheresis in COVID-19 patients


An article by ntv Wissen reported on the use of CRP apheresis in COVID-19 patients at the Gemeinschaftskrankenhaus Havelhöhe.

You can read the article in German here .

Promising treatment success in patients with severe COVID-19 courses

Hennigsdorf, 21.04.2021 – Pentracor GmbH, a medical technology company based in Hennigsdorf near Berlin (convertible bond ISIN: DE000A289XB9, WKN: A289XB), active in the dynamically growing healthcare sector, has achieved further promising treatment successes with its CE-certified and patent-protected medical product PentraSorb® CRP in patients with severe COVID-19 courses. For example, the Havelhöhe Community Hospital in Berlin has been using Pentracor's new therapeutic extracorporeal treatment method for severely ill COVID-19 patients for several weeks and has already achieved a significant improvement in the patients' clinical condition after a short period of time.

CRP apheresis at the Klinikum Havelhöhe shown in the rbb Abendschau


COVID-19 patients are treated with CRP apheresis at the Klinikum Havelhöhe. This was featured in the rbb Abendschau.